-

Partnership for Safe Medicines Applauds International Criminal Police Organization (INTERPOL) for Seizure of $11 Million in Counterfeit Medicines During Operation Pangea XV

Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines, gives an overview of Operation Pangea's success and the hard truths that remain about the worldwide illicit drug trade.

WASHINGTON--(BUSINESS WIRE)--The Partnership for Safe Medicines, a public health group committed to the safety of pharmaceutical medicines, applauds the International Criminal Police Organization (INTERPOL) for organizing the seizure of over $11 million in counterfeit medicines during Operation Pangea XV, an initiative to combat the global trafficking of counterfeit pharmaceuticals marketed and sold online. During the week-long annual operation, law enforcement officers from 94 countries fanned out to investigate and shut down websites selling illicit medical products.

“It is encouraging to see the hard work of our law enforcement officials pay off in another successful Operation Pangea,” said Tom Kubic, board chair and President of the Partnership for Safe Medicines. “This work is more important now than ever. As PSM continues to monitor the counterfeit pill crisis across the United States and online, we have tracked deaths due to fake pills sold on social media in 21 states.”

The work of INTERPOL member countries and participating law enforcement officers, including the United States Immigration and Customs Enforcement Intellectual Property Rights and Commercial Fraud Center (ICE-IPR), play a vital role in investigating, inspecting, and seizing illicit medicines and healthcare products. Collectively, they support INTERPOL’s mandate to make the world a safer place.

This year, the operation completed 7,800 seizures of illegal and misbranded medicines, including more than 317,000 counterfeit COVID-19 test kits, unsafe pre-filled syringes, counterfeit antibiotic pills, and more. Of the packages searched by law enforcement, 48 percent contained illegal or counterfeit medicine; at least 36 organized crime groups were behind these illegal products; and over 1,200 advertisements were found on all major social media platforms and messaging apps selling fake and illegal medicines.

“While these numbers are shocking, they are not wholly surprising given the similar trends we have seen across the United States,” said Kubic. “Drug traffickers continue to operate online and on social media platforms, selling adulterated, substandard, and counterfeit medicines that can have deadly consequences. Law enforcement personnel are unfortunately already overwhelmed by this problem, and deserve all the resources we can devote to the problem.”

The Partnership for Safe Medicines is committed to working with law enforcement, policymakers, and families who have lost loved ones to counterfeit medicines to ensure the resources are available to combat this crisis and our U.S. policies protect Americans.

About the Partnership for Safe Medicines
The Partnership for Safe Medicines (PSM) is a public health group comprised of non-profit organizations that handle medicine from the factory floor to the patient and are committed to the safety of prescription drugs. To learn more, visit www.safemedicines.org.

Contacts

Shabbir Imber Safdar, Executive Director, Partnership for Safe Medicines
editors@safemedicines.org

Industry:

Partnership for Safe Medicines

Release Versions
English

Contacts

Shabbir Imber Safdar, Executive Director, Partnership for Safe Medicines
editors@safemedicines.org

Social Media Profiles
PSM Twitter
More News From Partnership for Safe Medicines

New Report Reveals Illegal Ingredients for Knockoff Weight Loss Drugs Flooding into U.S. from Foreign Sources, Endangering Patient Safety

WASHINGTON--(BUSINESS WIRE)--The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss drugs) are flooding into the U.S. from foreign sources despite U.S. laws forbidding them from coming through the border. The U.S. Food and Drug Administration (FDA) has warned against drug compounders’ use of unauthorized bulk drug ingredients, semaglutide and tirzepati...

More Than 90% of Likely Voters Are Concerned About Safety and Regulation of Compounded Weight Loss Drugs

WASHINGTON--(BUSINESS WIRE)--Today, the Partnership for Safe Medicines unveiled the results of a national public opinion poll that shows more than 90% of likely voters are concerned about the safety, regulation, and efficacy of compounded medications for diabetes and obesity (or weight loss). Ninety percent say the FDA should use their existing authority to ensure these compounded weight loss drugs are safe. Compounded medicines serve an important role in the U.S. healthcare system when used to...

Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation

WASHINGTON--(BUSINESS WIRE)--Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the U.S. Food and Drug Administration’s final decision to approve Florida’s Canadian drug importation plan. “The United States government’s decision to approve Florida’s Canadian drug importation plan weakens our nation’s safe drug supply, putting American patients at risk. This decision breaks our closed loop system and opens the door to counter...
Back to Newsroom